Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: All infringers should pool their money and buy PTSC and share.

That would result in PTSC having approximately $4B market cap, and I believe the potential market for the MMP was estimated at about $2B some 3 years ago. While I would accept that with a huge smile, I will not hold my breath.

Dreaming along with you.

Cheers,

DG

Share
New Message
Please login to post a reply